- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.06. | Valion Bio, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.06. | Valion Bio, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 03.06. | Valion Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work | 2 | Seeking Alpha | ||
| 14.05. | Valion Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.05. | Valion Bio subsidiary secures exclusive NMR platform license | 1 | Investing.com | ||
| 14.05. | Valion Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Valion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial Results | 214 | PR Newswire | First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration of Velocity... ► Artikel lesen | |
| VALION BIO Aktie jetzt für 0€ handeln | |||||
| 05.05. | Valion Bio receives protocol for radiation syndrome drug study | 3 | Investing.com | ||
| 05.05. | Tivic Health Systems, Inc.: Valion Bio Receives First FDA-precedent Study Protocol From Niaid For Entolimod; Federal Agency To Fully Fund Bla-enabling In Vivo Program And Co-navigate FDA Submission | 213 | PR Newswire | Initial Study to Evaluate Entolimod for Gastrointestinal Tissue Preservation in Partial-Body Acute Radiation Syndrome - an Indication for Which No Currently Approved... ► Artikel lesen | |
| 04.05. | Valion Bio, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.04. | Tivic Health Systems Rebrands to Valion Bio | 2 | Contract Pharma | ||
| 24.04. | Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening | 2 | Benzinga.com | ||
| 23.04. | Tivic Health Systems, Inc.: Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model | 248 | PR Newswire | Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod Toward BARDA Funding and Strategic National Stockpile Procurement... ► Artikel lesen | |
| 23.04. | Tivic Health Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 31.03. | Tivic Health receives Ukraine request for radiation treatment | 6 | Investing.com | ||
| 31.03. | Tivic Health Systems: Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod | 403 | ACCESS Newswire | SAN ANTONIO, TX / ACCESS Newswire / March 31, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a clinical-stage immunotherapeutics company, today announced it has received a formal Request for Information... ► Artikel lesen | |
| 27.03. | Tivic Health Systems: Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference | 683 | ACCESS Newswire | Presentation will Cover Recent Corporate Milestones Including Securing Agreement with NIAID SAN ANTONIO, TX / ACCESS Newswire / March 27, 2026 / Tivic Health Systems, Inc. (Nasdaq:TIVC), a clinical-stage... ► Artikel lesen | |
| 26.03. | Tivic Health Systems: Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome | 576 | ACCESS Newswire | Armed Forces Radiobiology Research Institute (AFRRI) Will Conduct the Gastrointestinal Acute Radiation Syndrome (GI-ARS) Study SAN ANTONIO, TX / ACCESS Newswire / March 26, 2026 / Tivic Health Systems... ► Artikel lesen |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,081 | +1,50 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation Solution | BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)... ► Artikel lesen | |
| TANDEM DIABETES | 13,500 | +0,75 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| VERU | 3,065 | +0,16 % | VERU INC. - 8-K, Current Report | ||
| SENSEONICS | 4,860 | 0,00 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,070 | -1,83 % | Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors | BRISANE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest" or "Tempest Therapeutics") today announced the appointment of two independent directors, Drake... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 17,300 | +0,58 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,900 | 0,00 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| VYOME | 2,260 | -1,74 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| VIVANI MEDICAL | 1,170 | +6,36 % | Vivani Medical, Inc.: Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc. | Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company's name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent)... ► Artikel lesen | |
| STEREOTAXIS | 1,526 | +0,66 % | Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) | ||
| VIEMED HEALTHCARE | 10,200 | -3,77 % | Reportable, Inc.: Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 | Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD). Viemed's 1Q26 results... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,453 | +0,02 % | Vivos Therapeutics, Inc: Vivos' Vida Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants | ||
| TENON MEDICAL | 0,283 | -3,32 % | Tenon Medical, Inc.: Tenon Medical Announces FDA 510(k) Clearance for Catamaran SI Joint Fusion System | ~ Updated clearance incorporates various instrument upgrades, as well as per-procedure costs, improving unit economics driven by the reclassification of certain instruments from disposable to reusable... ► Artikel lesen | |
| SEASTAR MEDICAL | 4,940 | +0,41 % | SeaStar Medical Holding Corp - 8-K, Current Report |
Das Unternehmen VALION BIO INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,491 Euro und damit -1,50 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VALION BIO INC finden Sie auf Wallstreet Online.